Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Smokeless tobacco use in Sweden and other 17 European countries

ME. Leon, A. Lugo, P. Boffetta, A. Gilmore, H. Ross, J. Schüz, C. La Vecchia, S. Gallus,

. 2016 ; 26 (5) : 817-821. [pub] 20160405

Jazyk angličtina Země Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20014728

Grantová podpora
MR/K023195/1 Medical Research Council - United Kingdom

INTRODUCTION: The purpose of this study is to report prevalence and determinants of use of smokeless tobacco in a representative sample of men and women from Sweden, where Swedish snus sales are legal, and from 17 other European countries, where sales of smokeless tobacco are restricted. METHODS: In 2010, a face-to-face survey including information on current smokeless tobacco use was conducted in a representative sample of around 1000 individuals aged ≥15 years per country in Albania, Austria, Bulgaria, Czech Republic, Croatia, England, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Poland, Portugal, Romania, Spain and Sweden. RESULTS: In Sweden, the overall prevalence of smokeless tobacco use was 12.3% (20.7% in men, 3.5% in women). The corresponding estimate for other European countries combined was 1.1% (1.2% in men, 1.1% in women). Compared with never smokers, former smokers in Sweden were significantly more likely to use smokeless tobacco (odds ratio, OR: 2.67), whereas no difference in use was observed in other countries (OR: 1.04). Use of smokeless tobacco was similar among current smokers in Sweden (OR: 1.96) and in other countries (OR: 2.40) when contrasted to never smokers. In Sweden there were no differences in the number of cigarettes/day between smokers who also use smokeless tobacco (13.3 cigarettes/day) and exclusive cigarette smokers (12.9 cigarettes/day; P = 0.785). CONCLUSIONS: Excluding Sweden, current oral tobacco use was not commonly reported in the European countries surveyed and was similarly rare both in men and in women. In Sweden, however, use of smokeless tobacco was about 10-fold higher than the rest of Europe and more prevalent in men than in women.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20014728
003      
CZ-PrNML
005      
20201012134421.0
007      
ta
008      
200922s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurpub/ckw032 $2 doi
035    __
$a (PubMed)27048433
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Leon, Maria E $u Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France leonrouxm@iarc.fr.
245    10
$a Smokeless tobacco use in Sweden and other 17 European countries / $c ME. Leon, A. Lugo, P. Boffetta, A. Gilmore, H. Ross, J. Schüz, C. La Vecchia, S. Gallus,
520    9_
$a INTRODUCTION: The purpose of this study is to report prevalence and determinants of use of smokeless tobacco in a representative sample of men and women from Sweden, where Swedish snus sales are legal, and from 17 other European countries, where sales of smokeless tobacco are restricted. METHODS: In 2010, a face-to-face survey including information on current smokeless tobacco use was conducted in a representative sample of around 1000 individuals aged ≥15 years per country in Albania, Austria, Bulgaria, Czech Republic, Croatia, England, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Poland, Portugal, Romania, Spain and Sweden. RESULTS: In Sweden, the overall prevalence of smokeless tobacco use was 12.3% (20.7% in men, 3.5% in women). The corresponding estimate for other European countries combined was 1.1% (1.2% in men, 1.1% in women). Compared with never smokers, former smokers in Sweden were significantly more likely to use smokeless tobacco (odds ratio, OR: 2.67), whereas no difference in use was observed in other countries (OR: 1.04). Use of smokeless tobacco was similar among current smokers in Sweden (OR: 1.96) and in other countries (OR: 2.40) when contrasted to never smokers. In Sweden there were no differences in the number of cigarettes/day between smokers who also use smokeless tobacco (13.3 cigarettes/day) and exclusive cigarette smokers (12.9 cigarettes/day; P = 0.785). CONCLUSIONS: Excluding Sweden, current oral tobacco use was not commonly reported in the European countries surveyed and was similarly rare both in men and in women. In Sweden, however, use of smokeless tobacco was about 10-fold higher than the rest of Europe and more prevalent in men than in women.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a kouření $x epidemiologie $7 D012907
650    _2
$a užívání tabáku $x epidemiologie $7 D064424
650    _2
$a bezdýmný tabák $x statistika a číselné údaje $7 D014030
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Rumunsko $x epidemiologie $7 D012383
651    _2
$a Portugalsko $x epidemiologie $7 D011174
651    _2
$a Polsko $x epidemiologie $7 D011044
651    _2
$a Švédsko $7 D013548
651    _2
$a Albánie $x epidemiologie $7 D000415
651    _2
$a Rakousko $x epidemiologie $7 D001317
651    _2
$a Bulharsko $x epidemiologie $7 D002031
651    _2
$a Chorvatsko $x epidemiologie $7 D017523
651    _2
$a Česká republika $x epidemiologie $7 D018153
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a Finsko $x epidemiologie $7 D005387
651    _2
$a Francie $x epidemiologie $7 D005602
651    _2
$a Řecko $x epidemiologie $7 D006115
651    _2
$a Maďarsko $x epidemiologie $7 D006814
651    _2
$a Irsko $x epidemiologie $7 D007494
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lugo, Alessandra $u Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
700    1_
$a Boffetta, Paolo $u Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute and Institute for Translational Epidemiology, New York, USA.
700    1_
$a Gilmore, Anna $u Department for Health and UK Centre for Tobacco and Alcohol Studies, University of Bath, Bath, UK.
700    1_
$a Ross, Hana $u School of Economics, University of Cape Town, Cape Town, South Africa.
700    1_
$a Schüz, Joachim $u Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
700    1_
$a La Vecchia, Carlo $u Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
700    1_
$a Gallus, Silvano $u Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
773    0_
$w MED00012099 $t European journal of public health $x 1464-360X $g Roč. 26, č. 5 (2016), s. 817-821
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27048433 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200922 $b ABA008
991    __
$a 20201012134421 $b ABA008
999    __
$a ok $b bmc $g 1571866 $s 1104888
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 26 $c 5 $d 817-821 $e 20160405 $i 1464-360X $m European journal of public health $n Eur J Public Health $x MED00012099
GRA    __
$a MR/K023195/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20200922

Najít záznam

Citační ukazatele

Možnosti archivace